MAGEA1 and tarsal-carpal coalition syndrome: Among MAGE proteins, the expression of MAGE-A1–4 was examined in 57 samples of primary TCC, and varied from 21% (MAGE-A1) to 35% (MAGE-A2), with higher expression level in advanced tumours (Patard et al, 1995).